Amneal Makes Second US Biosimilar Launch With Filgrastim

Releuko Version Of Neupogen Follows Alymsys Bevacizumab Rival To Avastin

 
• By David Wallace
  
Filgrastim vial label
Amneal’s second biosimilar launch is filgrastim • Source: Shutterstock

More from Biosimilars

More from Products